AAAAAA

   
Results: 1-17 |
Results: 17
PLATELET-AGGREGATION IN-VITRO AND EX-VIVO IN NORMAL-PREGNANCY, PREGNANCY-INDUCED HYPERTENSION, AND PREECLAMPSIA
Authors: NISELL H GRUNEWALD C BERGLUND M KARLBERG KE LUNELL NO SYLVEN C
Citation: H. Nisell et al., PLATELET-AGGREGATION IN-VITRO AND EX-VIVO IN NORMAL-PREGNANCY, PREGNANCY-INDUCED HYPERTENSION, AND PREECLAMPSIA, Hypertension in pregnancy, 17(2), 1998, pp. 147-155
INTRAVENOUS NITROGLYCERIN REDUCES ISCHEMIA IN UNSTABLE ANGINA-PECTORIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Authors: KARLBERG KE SALDEEN T WALLIN R HENRIKSSON P NYQUIST O SYLVEN C
Citation: Ke. Karlberg et al., INTRAVENOUS NITROGLYCERIN REDUCES ISCHEMIA IN UNSTABLE ANGINA-PECTORIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Journal of internal medicine, 243(1), 1998, pp. 25-31
INTERACTION OF NITROGLYCERIN AND ACETYLSA LICYLIC-ACID
Authors: KARLBERG KE
Citation: Ke. Karlberg, INTERACTION OF NITROGLYCERIN AND ACETYLSA LICYLIC-ACID, Perfusion, 10(1), 1997, pp. 36-36
MORE FAVORABLE EFFECTS OF METOPROLOL THAN CAPTOPRIL IN PATIENTS WITH DILATED CARDIOMYOPATHY
Authors: JANSSON K KARLBERG KE NYLANDER E KARLSSON E NYQVIST O DAHLSTROM U
Citation: K. Jansson et al., MORE FAVORABLE EFFECTS OF METOPROLOL THAN CAPTOPRIL IN PATIENTS WITH DILATED CARDIOMYOPATHY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7142-7142
MORE FAVORABLE HEMODYNAMIC-EFFECTS FROM METOPROLOL THAN FROM CAPTOPRIL IN PATIENTS WITH DILATED CARDIOMYOPATHY
Authors: JANSSON K KARLBERG KE NYLANDER E KARLSSON E NYQUIST O DAHLSTROM U
Citation: K. Jansson et al., MORE FAVORABLE HEMODYNAMIC-EFFECTS FROM METOPROLOL THAN FROM CAPTOPRIL IN PATIENTS WITH DILATED CARDIOMYOPATHY, European heart journal, 18(7), 1997, pp. 1115-1121
PEAK SKELETAL-MUSCLE PERFUSION IS MAINTAINED IN PATIENTS WITH CHRONICHEART-FAILURE WHEN ONLY A SMALL MUSCLE MASS IS EXERCISED
Authors: MAGNUSSON G KAIJSER L SYLVEN C KARLBERG KE ISBERG B SALTIN B
Citation: G. Magnusson et al., PEAK SKELETAL-MUSCLE PERFUSION IS MAINTAINED IN PATIENTS WITH CHRONICHEART-FAILURE WHEN ONLY A SMALL MUSCLE MASS IS EXERCISED, Cardiovascular Research, 33(2), 1997, pp. 297-306
THE GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR BLOCKER TIROFIBAN NOT HEPARIN, COUNTERACTS PLATELET-AGGREGATION IN UNSTABLE ANGINA-PECTORIS/
Authors: MATTSSON E MARTINSSON A NYQVIST O RASMANIS G SYLVEN C KARLBERG KE
Citation: E. Mattsson et al., THE GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR BLOCKER TIROFIBAN NOT HEPARIN, COUNTERACTS PLATELET-AGGREGATION IN UNSTABLE ANGINA-PECTORIS/, The American journal of cardiology, 80(7), 1997, pp. 938
EFFECTS OF ADENOSINE ON EX-VIVO FILTRAGOMETRY PLATELET-AGGREGATION INRELATION TO PLASMA-LEVELS
Authors: JONZON B KARLBERG KE QUERROLFERRER V SYLVEN C
Citation: B. Jonzon et al., EFFECTS OF ADENOSINE ON EX-VIVO FILTRAGOMETRY PLATELET-AGGREGATION INRELATION TO PLASMA-LEVELS, Acta Physiologica Scandinavica, 159(3), 1997, pp. 245-248
EFFECT OF NICOTINE INFUSION IN HUMANS ON PLATELET-AGGREGATION AND URINARY-EXCRETION OF A MAJOR THROMBOXANE METABOLITE
Authors: NOWAK J ANDERSSON K BENTHIN G CHEN J KARLBERG KE SYLVEN C
Citation: J. Nowak et al., EFFECT OF NICOTINE INFUSION IN HUMANS ON PLATELET-AGGREGATION AND URINARY-EXCRETION OF A MAJOR THROMBOXANE METABOLITE, Acta Physiologica Scandinavica, 157(1), 1996, pp. 101-107
PLATELET AND LEUKOCYTE ACTIVATION AFTER MYOCARDIAL-INFARCTION - INFLUENCE OF ENALAPRIL
Authors: SYLVEN C HAGERMAN I KARLBERG KE CHEN J WALLIN R ENEROTH P BERGSTROM K SALDEEN T
Citation: C. Sylven et al., PLATELET AND LEUKOCYTE ACTIVATION AFTER MYOCARDIAL-INFARCTION - INFLUENCE OF ENALAPRIL, European heart journal, 16(12), 1995, pp. 1800-1806
SKELETAL-MUSCLE STRENGTH AND ENDURANCE IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO IDIOPATHIC DILATED CARDIOMYOPATHY
Authors: MAGNUSSON G ISBERG B KARLBERG KE SYLVEN C
Citation: G. Magnusson et al., SKELETAL-MUSCLE STRENGTH AND ENDURANCE IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO IDIOPATHIC DILATED CARDIOMYOPATHY, The American journal of cardiology, 73(4), 1994, pp. 307-309
EVIDENCE FOR TOLERANCE TO THE PLATELET INHIBITORY EFFECT OF NITROGLYCERIN
Authors: KARLBERG KE NOWAK J AHLNER J SYLVEN C
Citation: Ke. Karlberg et al., EVIDENCE FOR TOLERANCE TO THE PLATELET INHIBITORY EFFECT OF NITROGLYCERIN, The American journal of cardiology, 73(13), 1994, pp. 958-959
STREPTOKINASE, BUT NOT TISSUE-PLASMINOGEN ACTIVATOR, ATTENUATES PLATELET-AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: KARLBERG KE CHEN J HAGERMAN I BERGSTROM K WALLIN R SALDEEN T SYLVEN C
Citation: Ke. Karlberg et al., STREPTOKINASE, BUT NOT TISSUE-PLASMINOGEN ACTIVATOR, ATTENUATES PLATELET-AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of internal medicine, 234(5), 1993, pp. 513-519
SIN-1 PARTIALLY AND RGDS TOTALLY COUNTERACTS PLATELET-AGGREGATION AS ASSESSED IN-VITRO BY 2 INDEPENDENT WHOLE-BLOOD METHODS
Authors: KARLBERG KE CHEN JH EGBERG N SYLVEN C
Citation: Ke. Karlberg et al., SIN-1 PARTIALLY AND RGDS TOTALLY COUNTERACTS PLATELET-AGGREGATION AS ASSESSED IN-VITRO BY 2 INDEPENDENT WHOLE-BLOOD METHODS, Thrombosis research, 72(6), 1993, pp. 531-540
COMPARISON OF 3 INDEPENDENT METHODS AS ESTIMATES OF PLATELET INHIBITION AFTER A SINGLE-DOSE OF ACETYLSALICYLIC-ACID
Authors: KARLBERG KE CHEN J EGBERG N NOWAK J SYLVEN C
Citation: Ke. Karlberg et al., COMPARISON OF 3 INDEPENDENT METHODS AS ESTIMATES OF PLATELET INHIBITION AFTER A SINGLE-DOSE OF ACETYLSALICYLIC-ACID, Scandinavian journal of clinical & laboratory investigation, 53(8), 1993, pp. 835-841
TOLERANCE TO NITROGLYCERINE DEVELOPS AGAINST IT PLATELET ANTIAGGREGATORY AS WELL AS VASODILATORY EFFECTS
Authors: KARLBERG KE SYLVEN C
Citation: Ke. Karlberg et C. Sylven, TOLERANCE TO NITROGLYCERINE DEVELOPS AGAINST IT PLATELET ANTIAGGREGATORY AS WELL AS VASODILATORY EFFECTS, Circulation, 88(4), 1993, pp. 348-348
MAXIMAL PERFUSION OF SKELETAL-MUSCLE IN PATIENTS WITH CHRONIC HEART-FAILURE
Authors: MAGNUSSON G KARLBERG KE KAIJSER L ISBERG B SYLVEN C SALTIN B
Citation: G. Magnusson et al., MAXIMAL PERFUSION OF SKELETAL-MUSCLE IN PATIENTS WITH CHRONIC HEART-FAILURE, Circulation, 88(4), 1993, pp. 591-591
Risultati: 1-17 |